Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 82.46%1.3B | 49.12%661.8M | 22.74%259.6M | 4.59%1.04B | -2.87%714.22M | -2.71%443.81M | -11.39%211.5M | -8.34%994.34M | -9.60%735.31M | -19.41%456.16M |
| Operating revenue | 82.46%1.3B | 49.12%661.8M | 22.74%259.6M | 4.59%1.04B | -2.87%714.22M | -2.71%443.81M | -11.39%211.5M | -8.34%994.34M | -9.60%735.31M | -19.41%456.16M |
| Other operating revenue | ---- | -30.25%4.49M | ---- | 32.97%11.56M | ---- | 125.32%6.44M | ---- | 17.83%8.7M | ---- | 39,132.93%2.86M |
| Total operating cost | 97.45%1.23B | 56.67%610.76M | 32.39%253.79M | 2.15%935.67M | -7.38%622.03M | -6.95%389.85M | -13.82%191.7M | -11.09%915.97M | -12.85%671.61M | -21.19%418.96M |
| Operating cost | 101.12%1.14B | 55.41%551.68M | 29.89%228.03M | -0.06%846.59M | -9.22%567.3M | -9.13%354.97M | -16.16%175.56M | -13.45%847.09M | -15.32%624.88M | -23.65%390.64M |
| Operating tax surcharges | 17.36%8.8M | 14.01%5.56M | 68.37%2.56M | 80.70%9.82M | 97.03%7.5M | 114.94%4.88M | 39.37%1.52M | 59.32%5.44M | 52.79%3.8M | 38.72%2.27M |
| Operating expense | 0.19%10.82M | -3.78%7.02M | -16.23%3.43M | -2.05%15.81M | 2.74%10.8M | 16.35%7.3M | 41.22%4.09M | 9.08%16.14M | 19.81%10.51M | 10.43%6.27M |
| Administration expense | 91.62%49.37M | 115.95%34.77M | 74.39%13.15M | 39.25%46.64M | 7.38%25.76M | 8.86%16.1M | 15.17%7.54M | 24.12%33.49M | 27.93%23.99M | 29.05%14.79M |
| Financial expense | 89.76%17.1M | 108.01%10.97M | 160.67%6.23M | 21.19%13.88M | 42.10%9.01M | 43.95%5.28M | 31.50%2.39M | 212.53%11.45M | 648.06%6.34M | 2,986.90%3.66M |
| -Interest expense (Financial expense) | 116.78%10.81M | 158.72%8.1M | 21.79%4.29M | 17.82%14.8M | -42.07%4.99M | -42.66%3.13M | 25.45%3.52M | 146.05%12.56M | 36.49%8.61M | 32.50%5.46M |
| -Interest Income (Financial expense) | 91.95%-172.56K | 92.27%-144.31K | 94.66%-69.82K | 38.07%-2.29M | 25.33%-2.14M | 8.48%-1.87M | -18.28%-1.31M | 47.67%-3.69M | 49.91%-2.87M | 51.52%-2.04M |
| Research and development | -28.51%1.2M | -42.98%750.35K | -35.79%386K | 24.35%2.93M | -19.60%1.67M | -0.36%1.32M | -13.33%601.16K | -7.91%2.35M | 16.22%2.08M | 21.22%1.32M |
| Credit Impairment Loss | -180.53%-6.82M | -126.88%-2.92M | -31.84%-3M | 83.02%-662.87K | 43.25%-2.43M | 41.02%-1.29M | 18.56%-2.28M | -1,801.58%-3.9M | -197.83%-4.28M | 22.49%-2.18M |
| Asset Impairment Loss | ---973.6K | --64.31K | --331.34K | -589.28%-2.35M | ---- | ---- | ---- | ---341.27K | ---- | ---- |
| Other net revenue | 276.66%3.33M | 586.71%6.66M | 28.25%-684K | -57.75%3.29M | -78.98%884.16K | -77.58%970.03K | 27.58%-953.26K | 456.21%7.78M | 1,509.78%4.21M | 302.75%4.33M |
| Invest income | ---- | ---- | ---- | 2,708.31%758.49K | --642.43K | --525K | --262.5K | ---29.08K | ---- | ---- |
| Asset deal income | 317.18%6.67M | 790.11%6.45M | -221.17%-77.71K | 1,367.98%2.3M | 571.54%1.6M | 550.93%724.91K | 8.03%64.13K | 104.51%156.62K | 7,059.51%238.05K | 296.84%111.37K |
| Other revenue | 314.77%4.45M | 204.19%3.07M | 106.96%2.07M | -72.73%3.24M | -86.99%1.07M | -84.24%1.01M | -29.78%998.11K | 156.18%11.9M | 621.91%8.25M | 764.15%6.4M |
| Operating profit | -15.88%78.29M | 5.02%57.7M | -72.81%5.13M | 24.94%107.63M | 37.05%93.07M | 32.29%54.94M | 26.31%18.85M | 53.80%86.15M | 59.82%67.91M | 28.68%41.53M |
| Add:Non operating Income | -86.73%464.92K | -95.76%146.01K | -99.07%31.38K | 768.54%3.66M | 606.60%3.5M | 880.01%3.44M | 2,131.84%3.38M | 31.79%420.84K | 5.32%495.64K | 7.84%351.16K |
| Less:Non operating expense | 21.86%4.17M | -2.93%3.16M | 13.70%1.34M | 134.70%4.73M | 253.74%3.42M | 467.82%3.25M | 1,020.98%1.18M | -8.09%2.01M | -50.71%968.22K | -60.73%573.1K |
| Total profit | -19.93%74.58M | -0.80%54.69M | -81.88%3.81M | 26.02%106.56M | 38.13%93.15M | 33.45%55.13M | 40.61%21.05M | 56.17%84.56M | 64.49%67.43M | 32.65%41.31M |
| Less:Income tax cost | 10.90%28.32M | 19.58%18.63M | 8.74%6.82M | 51.49%33.89M | 44.42%25.53M | 56.66%15.58M | 44.08%6.27M | 61.58%22.37M | 56.92%17.68M | 24.93%9.94M |
| Net profit | -31.58%46.26M | -8.83%36.06M | -120.37%-3.01M | 16.86%72.67M | 35.89%67.61M | 26.10%39.55M | 39.19%14.77M | 54.32%62.19M | 67.35%49.75M | 35.31%31.36M |
| Net profit from continuing operation | -31.58%46.26M | -8.83%36.06M | -120.37%-3.01M | 16.86%72.67M | 35.89%67.61M | 26.10%39.55M | 39.19%14.77M | 54.32%62.19M | 67.35%49.75M | 35.31%31.36M |
| Less:Minority Profit | -37,237.03%-12.99M | ---4.75M | ---10.85M | ---8.9M | ---34.78K | ---- | ---- | --0 | ---- | ---- |
| Net profit of parent company owners | -12.42%59.24M | 3.18%40.81M | -46.93%7.84M | 31.17%81.57M | 35.96%67.65M | 26.10%39.55M | 39.19%14.77M | 54.32%62.19M | 67.35%49.75M | 35.31%31.36M |
| Earning per share | ||||||||||
| Basic earning per share | -12.20%0.36 | 4.17%0.25 | -45.45%0.06 | 33.33%0.64 | 5.13%0.41 | 0.00%0.24 | 37.50%0.11 | 54.84%0.48 | 69.57%0.39 | 33.33%0.24 |
| Diluted earning per share | -12.20%0.36 | 4.17%0.25 | -45.45%0.06 | 33.33%0.64 | 5.13%0.41 | 0.00%0.24 | 37.50%0.11 | 54.84%0.48 | 69.57%0.39 | 33.33%0.24 |
| Other composite income | ||||||||||
| Total composite income | -31.58%46.26M | -8.83%36.06M | -120.37%-3.01M | 16.86%72.67M | 35.89%67.61M | 26.10%39.55M | 39.19%14.77M | 54.32%62.19M | 67.35%49.75M | 35.31%31.36M |
| Total composite income of parent company owners | -12.42%59.24M | 3.18%40.81M | -46.93%7.84M | 31.17%81.57M | 35.96%67.65M | 26.10%39.55M | 39.19%14.77M | 54.32%62.19M | 67.35%49.75M | 35.31%31.36M |
| Total composite income of minority owners | -37,237.03%-12.99M | ---4.75M | ---10.85M | ---8.9M | ---34.78K | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.